ConductScience.org, home

Paper3533974

Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.

Doern GV and 3 others. J Clin Microbiol, 1986. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts. Papers, record 3533974. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3533974

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
PubMed
Journal
J Clin Microbiol
PubMed
Year
1986
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
2.75
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Doern GVG V
2Tubert TAT A
3Chapin KK
4Rinaldi MGM G

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amphotericin BMajor topic
FlucytosineMajor topic
KetoconazoleMajor topic
MiconazoleMajor topic
YeastsMajor topic
Candida
Candida albicans
Cryptococcus neoformans
Culture Media
Humans
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14561725Obfuscation of the activity of antifungal antimicrobics by culture media.J Infect Dis1972https://conductscience.org/library/papers/4561725PubMed
23517051Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.J Clin Microbiol1986https://conductscience.org/library/papers/3517051PubMed
34598611Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4598611PubMed
41091999The action of miconazole of the growth of Candida albicans.Sabouraudia1975https://conductscience.org/library/papers/1091999PubMed
5984806Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984806PubMed
6584152Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/584152PubMed
724676Factors influencing the susceptibility of Candida albicans to the polyenoic antibiotics nystatin and amphotericin B.J Gen Microbiol1978https://conductscience.org/library/papers/24676PubMed
8464576Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/464576PubMed
97416742Incidence of polyene-resistant yeasts recovered from clinical specimens.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7416742PubMed
106753737Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6753737PubMed
116299178Effects of pH on the activity of ketoconazole against Candida albicans.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6299178PubMed
126322363Azole resistance in Candida albicans.Sabouraudia1984https://conductscience.org/library/papers/6322363PubMed
136391370Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6391370PubMed
143905985Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole.J Infect Dis1985https://conductscience.org/library/papers/3905985PubMed
154799552In vitro activity of 5-fluorocytosine against Candida and Torulopsis species.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4799552PubMed

Download CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
42182847Invasive Fusariosis: A Retrospective Case Series Evaluating In Vitro Minimum Inhibitory Concentrations and Clinical Response.Open Forum Infect Dis2026https://conductscience.org/library/papers/42182847PubMed
37888229The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing.J Fungi (Basel)2023https://conductscience.org/library/papers/37888229PubMed
32604845The Effect of Growth Medium Strength on Minimum Inhibitory Concentrations of Tannins and Tannin Extracts against E. coli.Molecules2020https://conductscience.org/library/papers/32604845PubMed
29371537Antifungal Susceptibility Testing of Fusarium: A Practical Approach.J Fungi (Basel)2017https://conductscience.org/library/papers/29371537PubMed
26426003Activity of Polyphenolic Compounds against Candida glabrata.Molecules2015https://conductscience.org/library/papers/26426003PubMed
22416196Comparative antifungal activity of cilofungin (LY121019) against Candida species, including evaluation of susceptibility testing method.Can J Infect Dis1992https://conductscience.org/library/papers/22416196PubMed
21969752Synthesis, in vitro and in vivo antifungal activity of 5-phenylthio-2,4-bisbenzyloxypyrimidine: a novel nucleobase.Indian J Pharm Sci2010https://conductscience.org/library/papers/21969752PubMed
19704126A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19704126PubMed
11086482Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading.Mycopathologia1999https://conductscience.org/library/papers/11086482PubMed
8354299Evaluation of five commercial antifungal susceptibility testing systems.Eur J Clin Microbiol Infect Dis1993https://conductscience.org/library/papers/8354299PubMed
8285631Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8285631PubMed
8269392Antifungal susceptibility testing.Clin Microbiol Rev1993https://conductscience.org/library/papers/8269392PubMed
8150963Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.J Clin Microbiol1994https://conductscience.org/library/papers/8150963PubMed
7814488
Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
J Clin Microbiol1994https://conductscience.org/library/papers/7814488PubMed
7763718Determination of anti-Aspergillus activity of antifungal agents based on the dynamic growth rate of a single hypha.Appl Microbiol Biotechnol1993https://conductscience.org/library/papers/7763718PubMed
3326524Antifungal susceptibility tests.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3326524PubMed
3300534Broth dilution testing of Candida albicans susceptibility to ketoconazole.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3300534PubMed
3235657Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing.J Clin Microbiol1988https://conductscience.org/library/papers/3235657PubMed
2811982Ketoconazole resistance in Torulopsis glabrata.Mycopathologia1989https://conductscience.org/library/papers/2811982PubMed
2751286pH and other effects on the antifungal activity of cilofungin (LY121019).Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2751286PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3533974

GET https://conductscience.org/api/papers/v1/3533974/cited_by?page=2